首页> 美国卫生研究院文献>Netherlands Heart Journal >One-year efficacy and safety of routine prasugrel in patients with acute coronary syndromes treated with percutaneous coronary intervention: results of the prospective rijnmond collective cardiology research study

【2h】

One-year efficacy and safety of routine prasugrel in patients with acute coronary syndromes treated with percutaneous coronary intervention: results of the prospective rijnmond collective cardiology research study

机译：经皮冠状动脉介入治疗急性冠脉综合征患者常规普拉格雷治疗的一年疗效和安全性：前列宁蒙德集体心脏病学研究结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo investigate 1‑year outcomes with routine prasugrel treatment after acute coronary syndrome (ACS) in a large-scale registry.

机译：目的在大规模注册研究中研究急性冠脉综合征（ACS）后常规普拉格雷治疗1年的预后。

著录项

期刊名称 Netherlands Heart Journal
作者
T. Yetgin; E. Boersma; P. C. Smits; A. G. de Vries; E. Huijskens; F. Zijlstra; M. M. J. M. van der Linden; R. J. M. van Geuns;
展开▼
作者单位

展开▼
年(卷),期 2018(26),7-8
年度 2018
页码 393–400
总页数 8
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Acute coronary syndrome Percutaneous coronary intervention Prasugrel;

机译：急性冠状动脉综合征;经皮冠状动脉介入治疗;普拉格雷;

相似文献

外文文献
中文文献
专利

1. One-year efficacy and safety of routine prasugrel in patients with acute coronary syndromes treated with percutaneous coronary intervention: results of the prospective rijnmond collective cardiology research study [J] . T. Yetgin, E. Boersma, P. C. Smits, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation . 2018,第7a8期

机译：经皮冠状动脉介入治疗急性冠脉综合征患者常规普拉格雷的一年疗效和安全性：前瞻性rijnmond集体心脏病研究的结果
2. Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet Therapy after percutaneous coronary intervention in patients with acute coronary syndromes ( SMART-DATE) prospective multicenter randomized trial [J] . Lee Joo Myung, Cho Deok-Kyu, Hahn Joo-Yong, The American heart journal . 2016,第期

机译：急性冠状动脉综合征患者经皮冠状动脉干预后6个月持续时间持续时间：理论与设计急性冠状动脉患者急性冠状动脉经皮冠状动脉介入后6个月持续时间急性血管成形术研究团队 - 安全性综合征（智能日期）预期多中心随机试验
3. One-Year Post-Discharge Resource Utilization and Treatment Patterns of Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention and Treated with Ticagrelor or Prasugrel [J] . Simeone Jason C., Molife Cliff, Marrett Elizabeth, American journal of cardiovascular drugs: drugs, devices, and other interventions . 2015,第5期

机译：经皮冠状动脉介入治疗并替卡格雷或普拉格雷治疗急性冠脉综合征的一年放电后资源利用和治疗方式
4. Evaluation of Matrix Metalloproteinase-9 (MMP-9) and its tissue inhibitor of metalloproteinase-1 (Timp-1) in patients with coronary syndromes after percutaneous intervention(PCI) [C] . Revnic F., Revnic C.R., Nica A., International Congress on Coronary Artery Disease . 2011

机译：经皮干预后冠状动脉综合征患者中基质金属蛋白酶-9（MMP-9）及其组织抑制剂及其组织抑制剂（PCI）
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes [O] . T. Yetgin, M. M. J. M. van der Linden, A. G. de Vries, 2014

机译：在常规实践中采用普拉格雷：Rijnmond集体心脏病学（CCR）研究在急性冠脉综合征的经皮冠状动脉介入治疗中的理论基础和设计
7. Adoption of prasugrel into routine practice: Rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes [O] . Yetgin, T., Linden, M.M.J.M. (Mark) van der, Vries, A.G. (A.) de, 2014

机译：在常规实践中采用普拉格雷：Rijnmond集体心脏病研究（CCR）研究在急性冠脉综合征的经皮冠状动脉介入治疗中的原理和设计

One-year efficacy and safety of routine prasugrel in patients with acute coronary syndromes treated with percutaneous coronary intervention: results of the prospective rijnmond collective cardiology research study

摘要

著录项

相似文献

相关主题

期刊订阅